{"id":36030,"date":"2025-10-21T15:44:43","date_gmt":"2025-10-21T13:44:43","guid":{"rendered":"https:\/\/ggba.swiss\/?p=36030"},"modified":"2025-10-21T15:44:46","modified_gmt":"2025-10-21T13:44:46","slug":"aspivix-launches-its-breakthrough-carevix-device-in-the-united-states","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/","title":{"rendered":"Aspivix launches its breakthrough Carevix device in the United States"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.aspivix.com\/\">Aspivix<\/a>, the Lausanne-based FemTech innovator transforming gynecological care, has officially launched its Carevix device in the United States. The company\u2019s suction-based cervical stabilizer, a modern alternative to the century-old tenaculum, is now available to physicians in Southern California and New York, marking a major milestone in its U.S. commercialization strategy.<\/p>\n\n\n\n<p>Carevix uses gentle suction instead of sharp forceps to stabilize the cervix during intrauterine device (IUD) insertions and other gynecological procedures. Clinical data show the device reduces pain by over 70% and bleeding by more than 80% compared to traditional tools, providing a significant advance in women\u2019s health comfort and safety.<\/p>\n\n\n\n<p>The U.S. launch follows years of development and validation, including FDA clearance, CE marking, and recognition by <em>TIME<\/em> magazine as one of the 200 Best Inventions of 2024. A new report in <em>BMJ Sexual &amp; Reproductive Health<\/em> further confirmed Carevix\u2019s clinical value, highlighting high satisfaction rates among both patients and healthcare providers in Sweden.<\/p>\n\n\n\n<p>\u201cAs we launch in Los Angeles, Orange County, and New York, we\u2019re not just introducing a new device \u2014 we\u2019re redefining the standard of gynecological care,\u201d said Mathieu Horras, CEO and co-founder of Aspivix.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Advancing women\u2019s healthcare innovation worldwide<\/h4>\n\n\n\n<p>Aspivix\u2019s expansion builds on successful pilot programs with Indiana University Health, Columbia University, and Tia Health. Over 1,200 procedures across nine countries provided real-world evidence supporting Carevix\u2019s safety, efficacy, and ease of adoption.<\/p>\n\n\n\n<p>In the U.S., healthcare professionals can now order Carevix directly through the new portal <a href=\"https:\/\/www.myaspivix.us\/\">myaspivix.us<\/a>, with training and on-site support available in both regions.<\/p>\n\n\n\n<p>\u201cWe\u2019re giving women and people with a uterus access to a gentler, more respectful experience, because gynecological pain can and should be reduced,\u201d said Ikram Guerd, General Manager U.S. of Aspivix.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vaud-based FemTech company Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.<\/p>\n","protected":false},"author":6,"featured_media":36031,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[890,963,926,886],"class_list":["post-36030","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-healthcare","tag-medical-devices","tag-medtech","tag-rd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aspivix launches its Carevix device in the United States | GGBa<\/title>\n<meta name=\"description\" content=\"Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aspivix launches its Carevix device in the United States | GGBa\" \/>\n<meta property=\"og:description\" content=\"Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-21T13:44:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-21T13:44:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Aspivix-Carevix-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1292\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Aspivix launches its breakthrough Carevix device in the United States\",\"datePublished\":\"2025-10-21T13:44:43+00:00\",\"dateModified\":\"2025-10-21T13:44:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/\"},\"wordCount\":300,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Aspivix-Carevix-1180x811-1.jpeg\",\"keywords\":[\"Healthcare\",\"Medical Devices\",\"Medtech\",\"R&amp;D\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/\",\"url\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/\",\"name\":\"Aspivix launches its Carevix device in the United States | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Aspivix-Carevix-1180x811-1.jpeg\",\"datePublished\":\"2025-10-21T13:44:43+00:00\",\"dateModified\":\"2025-10-21T13:44:46+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Aspivix-Carevix-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Aspivix-Carevix-1180x811-1.jpeg\",\"width\":1920,\"height\":1292,\"caption\":\"Aspivix\u2019s Carevix device offers a gentler alternative to the century-old tenaculum, using suction instead of sharp forceps to reduce pain and bleeding during gynecological procedures. | \u00a9 Aspivix\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aspivix launches its breakthrough Carevix device in the United States\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aspivix launches its Carevix device in the United States | GGBa","description":"Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/","og_locale":"en_US","og_type":"article","og_title":"Aspivix launches its Carevix device in the United States | GGBa","og_description":"Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.","og_url":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-10-21T13:44:43+00:00","article_modified_time":"2025-10-21T13:44:46+00:00","og_image":[{"width":1920,"height":1292,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Aspivix-Carevix-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Aspivix launches its breakthrough Carevix device in the United States","datePublished":"2025-10-21T13:44:43+00:00","dateModified":"2025-10-21T13:44:46+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/"},"wordCount":300,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Aspivix-Carevix-1180x811-1.jpeg","keywords":["Healthcare","Medical Devices","Medtech","R&amp;D"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/","url":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/","name":"Aspivix launches its Carevix device in the United States | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Aspivix-Carevix-1180x811-1.jpeg","datePublished":"2025-10-21T13:44:43+00:00","dateModified":"2025-10-21T13:44:46+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Aspivix-Carevix-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Aspivix-Carevix-1180x811-1.jpeg","width":1920,"height":1292,"caption":"Aspivix\u2019s Carevix device offers a gentler alternative to the century-old tenaculum, using suction instead of sharp forceps to reduce pain and bleeding during gynecological procedures. | \u00a9 Aspivix"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/aspivix-launches-its-breakthrough-carevix-device-in-the-united-states\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Aspivix launches its breakthrough Carevix device in the United States"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/36030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=36030"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/36030\/revisions"}],"predecessor-version":[{"id":36034,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/36030\/revisions\/36034"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/36031"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=36030"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=36030"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=36030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}